APP and Alzheimer disease: Genetic manipulation designed to damage APP axonal transport in AD mouse models, such as Tg-swAPPPrp, demonstrated the enhancement in the incidence of axonal swellings, elevated Aβ levels, and potentiated the production of amyloid deposition [142].